Lucia Occhi

Lucia Occhi

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2024 in Circulation: Heart Failure
Verified
Journal Article
Closed access
EAEnrico Ammirati
Enrico Ammirati
DMDavide Marchetti
Davide Marchetti
GCGiada Colombo
Giada Colombo
PPPierpaolo Pellicori
Pierpaolo Pellicori
PGPiero Gentile
Piero Gentile
GAGARASCIA ANDREA
GARASCIA ANDREA
BACKGROUND: Clinical evaluation of central venous pressure is difficult, depends on experience, and is often inaccurate in patients with chronic advanced heart failure. We assessed the ultrasound-assessed internal jugular vein (JV) distensibility by ultrasound as a noninvasive tool to identify patients with normal right atrial pressure (RAP ≤7 mm Hg) in this population. METHODS: We measured JV distensibility as the Valsalva-to-rest ratio of the vein diameter in a calibration cohort (N=100) and a validation cohort (N=101) of consecutive patients with chronic heart failure with reduced ejection fraction who underwent pulmonary artery catheterization for advanced heart failure therapies workup. RESULTS: A JV distensibility threshold of 1.6 was identified as the most accurate to discriminate between patients with RAP ≤7 versus >7 mm Hg (area under the receiver operating characteristic curve, 0.74 [95% CI, 0.64–0.84]) and confirmed in the validation cohort (receiver operating characteristic, 0.82 [95% CI, 0.73–0.92]). A JV distensibility ratio >1.6 had predictive positive values of 0.86 and 0.94, respectively, to identify patients with RAP ≤7 mm Hg in the calibration and validation cohorts. Compared with patients from the calibration cohort with a high JV distensibility ratio (>1.6; n=42; median RAP, 4 mm Hg; pulmonary capillary wedge pressure, 11 mm Hg), those with a low JV distensibility ratio (≤1.6; n=58; median RAP, 8 mm Hg; pulmonary capillary wedge pressure, 22 mm Hg; P <0.0001 for both) were more likely to die or undergo a left ventricular assist device implant or heart transplantation (event rate at 2 years: 42.7% versus 18.2%; log-rank P =0.034). CONCLUSIONS: Ultrasound-assessed JV distensibility identifies patients with chronic advanced heart failure with normal RAP and better outcomes. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03874312.

22 January 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CCClaudia Colombo
Claudia Colombo
NCNicolò Capsoni
Nicolò Capsoni
Filippo RussoFilippo Russo
Filippo Russo
Mario IannacconeMario Iannaccone
Mario Iannaccone
MAMarianna Adamo
Marianna Adamo
ASAlice Sacco
Alice Sacco
Catheter-based revascularization procedures were developed as an alternative to systemic thrombolysis for patients with intermediate-high- and high-risk pulmonary embolisms. USAT IH-PE is a retrospective and prospective multicenter registry of such patients treated with ultrasound-facilitated, catheter-directed thrombolysis, whose preliminary results are presented in this study. The primary endpoint was the incidence of pulmonary hypertension (PH) at follow-up. Secondary endpoints were short- and mid-term changes in the echocardiographic parameters of right ventricle (RV) function, in-hospital and all-cause mortality, and procedure-related bleeding events. Between March 2018 and July 2023, 102 patients were included. The majority were at intermediate–high-risk PE (86%), were mostly female (57%), and had a mean age of 63.7 ± 14.5 years, and 28.4% had active cancer. Echocardiographic follow-up was available for 70 patients, and in only one, the diagnosis of PH was confirmed by right heart catheterization, resulting in an incidence of 1.43% (CI 95%, 0.036–7.7). RV echocardiographic parameters improved both at 24 h and at follow-up. In-hospital mortality was 3.9% (CI 95%, 1.08–9.74), while all-cause mortality was 11% (CI 95%, 5.4–19.2). Only 12% had bleeding complications, of whom 4.9% were BARC ≥ 3. Preliminary results from the USAT IH-PE registry showed a low incidence of PH, improvement in RV function, and a safe profile.

18 May 2023 in European Heart Journal Supplements
Verified
Journal Article
Open access
PDF file
SGS Guasti
S Guasti
FMF Musca
F Musca
ABAndrea Bonelli
Andrea Bonelli
GSG De Sanctis
G De Sanctis
RIRita Cristina Myriam Intravaia
Rita Cristina Myriam Intravaia
AMAntonella Moreo
Antonella Moreo
The patient is a 34–year–old man who comes to the emergency room with mild hemoptysis, asthenia, low–grade fever, night sweats and weight loss. Cardiac auscultation reveals a diastolic murmur at the cardiac apex. Transthoracic and transesophageal echocardiograms are performed and show an isoechoic thickening encompassing the posterior leaflet, cranially involving the atrial septum and the lateral wall up to the inlet of the left atrial appendage and inferiorly involveing the subvalvular apparatus with diffuse thickening and chordal fusion. Functionally it determines a moderate mitral stenosis with an average gradient of 10 mmHg and a valve area of ​​1.1 cm2 and a mild–moderate regurgitation with an anteriorly directed eccentric jet. At this point we needed to make the differential diagnosis considering as possible etiologies infective endocardic vegetation, thrombosis, primary and secondary neoplasms, aseptic vegetation and inflammatory or rheumatic valvulitis. We therefore begin our diagnostic work–up by performing a scintigraphy with labeled leukocytes, which does not show the presence of hyperuptake areas referable to infective endocarditis, and a PET scan which shows, in addition to the increased uptake at the cardiac level, an area of ​​greater concentration of the metabolic tracer in the gastric area (between the body and the fundus). Given the confirmation of metabolically active tissue, the patient performed cardiac magnetic resonance with contrast medium which confirmed the presence of pathological tissue with inhomogeneous late post–contrast enhancement. After collegial discussion, due to the high risk of biopsy of the mitral lesion, which was poorly separable from the cardiac structures, given the other localization of the disease at the gastric level, it was decided to perform an EGDS with relief of an ulcerated lesion on the gastric fundus which is subjected to biopsy and histological typing. We then arrive at the diagnosis of “undifferentiated pleomorphic sarcoma”. Sarcoma is the most frequent histological type of primary malignant cardiac tumors. The clinic is characterized by constitutional symptoms, obstruction of the valve inflow or outflow tract, thromboembolism, and arrhythmias. It has a poor prognosis: 6–12 months from diagnosis. In conclusion, we reiterate the importance of integrated imaging to arrive at the final diagnosis, each method with a specific objective. Open in new tab Download slide Open in new tab Download slide Open in new tab Download slide

18 May 2023 in European Heart Journal Supplements
Verified
Journal Article
Open access
PDF file
EGE Gualini
E Gualini
LOLucia Occhi
Lucia Occhi
GMG Maida
G Maida
PDP Dalino
P Dalino
PPPatrizia Pedrotti
Patrizia Pedrotti
CGC Giannattasio
C Giannattasio
Thyroid and cardiovascular system are inextricably related and cardiovascular complications can occur in both subclinical and overt thyroid dysfunction. We report the case of a 42–year–old woman presenting with chest pain. She had a positive SARS–CoV–2 swab in June and she was hospitalised in suspicion of COVID–related pneumonia and pericarditis in July: treatment with ibuprofen and colchicine was started and patient was discharged. On July 26th, the patient came back to emergency department due to worsening chest pain and myalgias after therapy decalage. She had face edema and hoarse voice. 12–leads EKG was normal; echocardiography showed 8 mm pericardial effusion and normal ejection fraction. Blood testing revealed no inflammatory signs, a mild increase of Troponin (peak value 19.1 ng/L, n.v. 0–14) and a high value of CPK (peak value 2299 U/L, 464 U/L at time of discharge, n.v. 30–150). Moreover, she had a biohumoral profile of Hashimoto thyroiditis: severe hypothyroidism with increase in TSH levels (538 microU/ml peak value, 322 microU/ml at time of discharge, n.v. 0.27–4.2) and positivity to thyroid autoantibodies. The patient underwent a cardiac magnetic resonance imaging that was suggestive for acute perimyocarditis with biventricular diffuse myocardial edema, preserved biventricular function and mild–to–moderate pericardial effusion. Low dose L–T4 therapy was started together with liothyronine that was stopped after few days, once acceptable FT3 concentrations were obtained. At echocardiography control after 8 days, we registered a significant reduction of pericardial effusion (2 mm). Myocarditis is an inflammatory disease of the myocardium and it is predominantly mediated by viral infection. A rare cause of myocarditis is represented by dysthyroidism. In our case, the severe hypothyroidism seems to be the cause of myocardial and pericardial edema. The failure in diagnosis of this endocrinological disorder can determine a delay in specific therapy with possible serious cardiovascular manifestations. So, it would be reasonable to check the thyroid status of all patients presenting with myopericarditis, in the absence of another clearly identifiable aetiology. The role of to the prior SARS–CoV–2 infection in not certain in our case, but the quick recovery after specific endocrinological therapy suggests the low probability of perimyocarditis as SARS–CoV2 related manifestation.

26 August 2022 in Life
Verified
Journal Article
Open access
PDF file
AMALESSANDRO MALOBERTI
ALESSANDRO MALOBERTI
JSJinwei Sun
Jinwei Sun
JZJessica Zannoni
Jessica Zannoni
LOLucia Occhi
Lucia Occhi
IBIlaria Bassi
Ilaria Bassi
CGCristina Giannattasio
Cristina Giannattasio
Endothelial dysfunction (ED) is frequently found in patients with heart failure (HF). Among several pharmacological agents reported to improve endothelial function, levosimendan seems to be a promising one, even though, to date, only two previously published studies have evaluated its effects on ED in these patients. The aim of our pilot study was to further investigate the role of periodic levosimendan infusion on endothelial function in patients affected by advanced HF. In this cross-sectional study, three different groups were enrolled: 20 patients with advanced HF treated with periodic levosimendan (LEVO), 20 patients with HF on optimal medical therapy (OMT), and 20 healthy subjects (control group). ED was evaluated through flow-mediated dilation (FMD) at the level of the brachial artery. The three groups presented similar ages with significant differences in gender distribution, systolic blood pressure, and chronic kidney disease (eGFR < 30 mL/min). In HF patients, ischaemic aetiology was more prevalent in the LEVO group than in the OMT group (60 vs. 40%, p < 0.001). The New York Heart Association (NYHA) functional class was worse in the LEVO group, as well as in NT-proBNP (5636.7 ± 6164.6 ng/dL and 1243.7 ± 1487.2 ng/dL, in the LEVO and OMT groups, respectively, p = 0.005). The FMD was significantly higher in the healthy control group compared to that of the OMT group (15.7 ± 6.4 vs. 9.1 ± 6.0%, p = 0.007) while it showed an intermediate value in LEVO patients (12.4 ± 7.1%) (ANOVA p = 0.010). In conclusion, levosimendan therapy seems to ameliorate endothelial dysfunction related to heart failure. Longitudinal studies in patients on periodic therapy are needed in order to confirm the long-term effects of levosimendan on ED.

31 July 2026 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
EGElena Gualini
Elena Gualini
PPPatrizia Pedrotti
Patrizia Pedrotti
PCPaolo Dalino Ciaramella
Paolo Dalino Ciaramella
GMGiulia Maida
Giulia Maida
LOLucia Occhi
Lucia Occhi
CGCristina Giannattasio
Cristina Giannattasio
Background: Severe hypothyroidism may present with cardiac manifestations, including pericardial effusion and myocardial oedema, which can mimic inflammatory myocardial and pericardial diseases. Recognition of this potentially reversible condition is crucial in the differential diagnosis of patients presenting with suspected myopericarditis. Case summary: A 42-year-old woman presented with recurrent chest pain initially suspected as relapsing myopericarditis following a recent SARS-CoV-2 infection. The electrocardiogram showed sinus rhythm with diffuse low-voltage QRS complexes. Transthoracic echocardiography demonstrated preserved biventricular systolic function and a circumferential pericardial effusion measuring up to 8 mm, without echocardiographic signs of cardiac tamponade. Laboratory tests revealed a markedly elevated creatine phosphokinase (>3000 U/L), mild troponin elevation, and severe hypothyroidism (thyroid-stimulating hormone: 538 µU/mL) with positive thyroid antibodies. Cardiac magnetic resonance demonstrated diffuse biventricular myocardial oedema and mild-to-moderate pericardial effusion without late gadolinium enhancement. In the context of severe hypothyroidism, these findings were considered consistent with cardiac myxoedema. Thyroid hormone replacement resulted in rapid clinical and echocardiographic improvement. The overall clinical, biochemical, and imaging findings supported severe hypothyroidism as the underlying cause. Discussion: This case highlights severe hypothyroidism as a reversible cause of myocardial oedema that may mimic inflammatory myopericarditis and should be considered in the differential diagnosis of patients presenting with myocardial oedema and pericardial effusion.